Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Lucid Diagnostics Inc. (LUCD)

NASDAQ

$0.81

$+0.01

(+1.68%)

Regular Market

Lucid Diagnostics Inc. (LUCD) Live Price Chart

Last updated: ⁦2026-09-16 14:41:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Lucid Diagnostics Inc. (LUCD) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $0.81, with a market capitalisation of $149.44M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.75 to $1.63. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$149.44M
Open	$0.79
Day's High	$13.52
Day's Low	$0.63
Previous Close	$0.79
Volume	172.02K
Average Volume	1.42M
P/E Ratio	--
52-Week High	$1.63
52-Week Low	$0.75
Dividend Yield	--
Earnings Date	--

Lucid Diagnostics Inc. (LUCD) Stock Price Today

Lucid Diagnostics Inc. (LUCD) is currently trading at $0.81 as of 2026-09-16 14:39:00, up 1.94% ($0.02) from the previous close of $0.79

During today's regular trading session, LUCD has traded between $0.63 and $13.52, with a trading volume of 172.02K shares. The current price is near the lower end of today's range.

Lucid Diagnostics Inc. (LUCD) 7-Day Stock Price Change

Over the past seven days, Lucid Diagnostics Inc. (LUCD) moved from $0.94 to $0.81, representing a decline of 13.89% ($0.13).

The stock traded between $0.75 and $0.96 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1.21 million shares, up versus the previous seven-day period, indicating higher trading activity.

LUCD 52-Week Price Position

Position in Range: 6.7%

52W Low$0.75

52W High$1.63

LUCD is currently trading at $0.81, placing it 6.7% of the way from its 52-week low of $0.75 to its 52-week high of $1.63. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Lucid Diagnostics Inc. (LUCD)?

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Lucid Diagnostics Inc. Information

Industry	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees	82
Exchange	NASDAQ
Company Website	https://www.luciddx.com

How to Buy Lucid Diagnostics Inc. (LUCD) Stock on MEXC

Eligible investors can buy real shares of Lucid Diagnostics Inc. (LUCD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for LUCD and Place Your Order

Open the RealStocks trading page and search for LUCD. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Lucid Diagnostics Inc. (LUCD) stock price today?

Lucid Diagnostics Inc. (LUCD) is currently trading at $ 0.81, up 1.94% ($0.02) from the previous close of $ 0.79. Intraday prices update in real time during regular trading hours.

2.Is LUCD stock going up or down today?

As of 2026-09-16 14:39:00, LUCD is trading at $ 0.81, up 1.94% ($0.02) from its previous close of $ 0.79. The stock has traded between $ 0.63 and $ 13.52 during today’s regular session. Past price movements do not guarantee future results.

3.What is LUCD pre-market price?

As of 2026-09-16 14:39:00, LUCD is trading at $ 0.79 in pre-market trading, down 0.96% ($0.01) from the previous close of $ 0.79. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is LUCD after-hours price?

As of 2026-09-16 14:39:00, LUCD is trading at $ 0.78 in after-hours trading, down 1.46% ($0.01) from the regular-session close of $ 0.79. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is LUCD stock trading now?

LUCD trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does LUCD sit relative to its 52-week high and low?

Over the past 52 weeks, LUCD has traded between a low of $ 0.75 and a high of $ 1.63. At $ 0.81, the stock is positioned 6.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Lucid Diagnostics Inc. in?

Lucid Diagnostics Inc. (LUCD) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Lucid Diagnostics Inc.'s market capitalisation and where is it listed?

Lucid Diagnostics Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 149.44M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is LUCD valued in terms of P/E ratio and EPS?

LUCD trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.34. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Lucid Diagnostics Inc. pay a dividend?

Lucid Diagnostics Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.